Optum

UnitedHealth Group financial performance and strategy

3 clusters · 24 sources · last updated 1 day ago

Latest: UnitedHealth discloses $2.1 million in lobbying expenditures

UnitedHealth Group reported third-quarter 2026 financial results that exceeded analyst expectations, with adjusted earnings of $4.69 per share against a consensus of $4.12 to $4.14. Total revenue reached $112.69 billion.

Celltrion biosimilar expansions in the United States

3 clusters · 7 sources · last updated 1 day ago

Latest: Celltrion secures exclusive US supply deals for Omlyclo and Aptozma

Celltrion has expanded its presence in the United States market through the launch and regulatory approval of multiple biosimilar products. In early October 2026, the company launched Omlyclo, the first omalizumab biosi

Celltrion financial performance and growth strategy

2 clusters · 8 sources · last updated 8 days ago

Latest: Celltrion targets 600 billion won operating profit for Q4

Celltrion has reported record-breaking financial performance, with third-quarter operating profits exceeding 500 billion won for the first time. This growth, characterized by a 69.2% increase in operating profit compared